REBECCA JORDAN: Open Payments
NPI 1437591146 · BELLEFONTE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 54 payments from 14 companies in 2025. Trend: 2023 $564 · 2024 $774 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $179 |
| PFIZER INC. | 14 | $145 |
| ABBVIE INC. | 5 | $99 |
| Lilly USA, LLC | 6 | $89 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Exact Sciences Corporation | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $22 |
| Amgen Inc. | 1 | $19 |
Products named: Ozempic, NURTEC ODT, MOUNJARO, XIFAXAN, UBRELVY, QULIPTA, PREVNAR 20, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
